Executive brief
AI Governance + Compliance is becoming a practical priority for life sciences organizations that want to move AI from theory into controlled operational use. Through the lens of AI Deployment & Workflow, the real question is not whether AI can create value. It is whether teams can deploy it into regulated environments with the right governance, process discipline, and accountability. Organizations that treat AI as a workflow design challenge, not just a technology investment, are more likely to create measurable value without introducing avoidable risk.
AI Governance + Compliance should be tied to workflow design, not treated as a standalone innovation topic.
AI deployment in life sciences succeeds when governance, process ownership, and change control are built in early.
Inline traceability, review points, and accountable oversight matter as much as technical capability.
The strongest AI programs connect strategic intent to daily execution inside real business workflows.
USDM content consistently supports an execution-first, regulated deployment approach.
AI Governance + Compliance is quickly becoming a practical requirement for life sciences teams that want to deploy AI responsibly. The challenge is not simply writing policies about AI. The challenge is translating those policies into governed workflows, controlled system behavior, accountable reviews, and evidence that can stand up under scrutiny. As AI governance life sciences discussions mature, leaders are realizing that deployment without oversight is just unmanaged risk. USDM’s AI in Life Sciences: 47 Use Cases for Quality, Regulatory, Clinical, and Manufacturing Teams helps ground that conversation in real operational use cases, where value and control have to coexist.